Gülfidan Aras

Gülfidan Aras

Auto-generated profile, based on publicly available information

Gülfidan Aras

Department of Chest Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2011 in COPD: Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Closed access
PDF file
GAGulfidan Aras
Gulfidan Aras
FKFigen Kadakal
Figen Kadakal
SPSevim Purisa
Sevim Purisa
DKDilek Kanmaz
Dilek Kanmaz
AAAysun Aynaci
Aysun Aynaci
EIElvan Işık
Elvan Işık
A few previous studies have reported that the patients with chronic obstructive pulmonary disease (COPD) have a 29.1% to 36.8% frequency of restless legs syndrome (RLS). In this study, we observed RLS symptoms in patients experiencing COPD exacerbation to better understand the relationship between the many clinical parameters of COPD and the presence of RLS and to attract the attention of specialists on the association between the two conditions. Twenty-two male patients in COPD exacerbation; 17 healthy individuals were evaluated in this study. The patients were evaluated using the 2003 RLS symptom criteria outlined by the International Restless Legs Syndrome Study Groups (IRLSSG). The Pittsburgh Sleep Quality Index and Epworth daytime sleepiness scale were used to assess the sleep quality of patients. The RLS symptoms were correlated with blood levels of laboratory and clinical parameters. Statistical analyses were performed using SPSS 17.0 statistical software packet. The Pittsburgh Sleep Quality Index and Epworth daytime sleepiness scale scores were increased in COPD patients and correlated significantly with RLS symptoms. It was found that 54.5% of COPD patients with acute exacerbations were observed to have RLS symptoms. The Pittsburgh Sleep Quality Index was significantly higher in COPD patients with RLS symptoms compared to COPD patients without RLS symptoms (p < 0.05). We did not observe any significant difference in the previously reported metabolic and clinical parameters associated with RLS in COPD patients with and without RLS. RLS symptoms increase during COPD exacerbation and lead to decreased sleep quality.

3 April 2021 in Family Practice and Palliative Care
Verified
Journal Article
Open access
PDF file
GAGülfidan Aras
Gülfidan Aras
FAFunda Seçi̇k Arkin
Funda Seçi̇k Arkin
EDElif Doğu
Elif Doğu
Introduction: Palliative Performance Scale (PPS), Karnofsky Performance Scale (KPS) and the Edmonton Symptom Assessment Scale (ESAS) are widely used prognostic scales in palliative care unit. Institutionalized palliative care services in our country are quite new compared to the practices in many countries. We do not have concrete data on the compatibility of these scales, which are developed with patient data from other countries, in our own palliative care practices with real cases. In this study, we aimed to evaluate the convenience of the Turkish versions of these scales on the first days of hospitalization of terminal cancer patients who were followed up in the palliative clinic of our hospital. We also questioned whether the initial estimated survival and actual survival were compatible. Methods: PPS, KPS and ESAS on the first days of hospitalization of terminal cancer patients, hospitalized in the palliative clinic of our hospital between November 14, 2016 and November 14, 2017, were retrospectively evaluated one year later (n = 222). The survivors and those who lost their lives were determined. The survival estimates with PPS of the patients who died were compared with their actual survival.Results: The average age of 222 patients (18% female, 82% male) participating in the study was 64.49 ± 11.62, and the range was 26-91. PPS, KPS, ESAS were determined as a mean value of 34.40±18.00 (min. 10-max. 90), 32.90±17.50 (min. 10-max. 90), 56.10±15.65 (min. 2-max. 90), respectively. The AUC of PPS is 0.83 (p<0.001) and the AUC of KPS is 0.78 (p<0.001) suggesting that KPS and PPS has at least one tie between alive and dead patients, which is 45%. Median survival time was found 14.00, 95% C.I. [10.87–17.13]. Conclusion: In our study, it was found that as the KPS and PPS scores decrease, the survival time of terminal cancer patients decrease. Patients with PPS <45% had a higher risk of death (sensitivity 71%, specificity 80%), patients with KPS 60.50 had a higher risk of death (sensitivity 93%, specificity 45%). PPS is a useful assessment scale for predicting survival of terminal cancer patients in the palliative care unit. We think it is important in determining our patient-specific palliative approach and treatments.

1 January 2024 in The Turkish Journal of Geriatrics
Verified
Journal Article
Closed access
ZKZehra Dilek Kanmaz
Zehra Dilek Kanmaz
TZTuğba MANDAL ZİREK
Tuğba MANDAL ZİREK
GAGülfidan Aras
Gülfidan Aras
ETEsin Tuncay
Esin Tuncay
Background: There is not enough information about the long-term effects of COVID-19 infection in those who have recovered. According to epidemiological studies, COVID-19 progresses less severely in countries where the Bacillus Calmette-Guerin vaccine is regularly applied than in those where it is not. The purified protein derivative of tuberculin is an indicator of the Bacillus Calmette-Guerin vaccine’s protective effectiveness against latent tuberculosis. In our study, we aimed to investigate the relationship between latent tuberculosisand the permanent effects of COVID-19.Our objective was to analyze the long-term relationship between latent tuberculosisand COVID-19. Materials and Method: We included all clinical, laboratory, and radiological baseline data of patients who were hospitalised for COVID-19 pneumonia between 2020 and 2021 during the pandemic in our study and compared them with data from six months later. Results: Although there was no statistically significant correlation between purified protein derivative of tuberculin positivity and the long-term effects of COVID-19 (p = 0.084), age exhibited a statistically significant relationship with the presence of post-COVID-19 sequelae (p = 0.004). Patients with chronic pulmonary disease displayed a significantly greater percentage of symptoms (p=0.005). Conclusion: We could not find any relationship between purified protein derivative of -tuberculin latent tuberculosis infection and long COVID-19 symptoms. We observed sequelae lesions more frequently in the follow-up of elderly patients. Post-COVID-19 symptoms were more common in patients with chronic lung disease. Thus, it is recommended to prioritise radiological and clinical follow-up in elderly patients and those with chronic lung conditions. Keywords: Post-Acute COVID-19 Syndrome, Latent Tuberculosis, COVID-19, Aged.

21 May 2026 in Journal of Pulmonology and Intensive Care
Verified
Journal Article
Closed access
GAGülfidan Aras
Gülfidan Aras
TZTuğba Mandal Zirek
Tuğba Mandal Zirek
ZKZehra Dilek Kanmaz
Zehra Dilek Kanmaz
FAFatma Tokgöz Akyıl
Fatma Tokgöz Akyıl
Aims: Patients with terminal lung cancer and COPD frequently require intensive care unit (ICU) care, yet survival benefits remain uncertain. We evaluated ICU outcomes and the impact of palliative care integration in a tertiary chest hospital. Methods: A retrospective review included 731 patients transferred to ICUs between 2013–2019. Outcomes were compared before and after the establishment of a palliative care unit in 2016. Results: Lung cancer accounted for 33.5% of cases and COPD for 66.5%. ICU mortality was 91.7% in cancer and 82% in COPD, with only 10.5% overall survival. Post-discharge survival remained poor, as 4.1% died shortly after ICU transfer. Mean ICU stays were 7.8 and 11.6 days, respectively. Palliative care availability did not significantly change ICU referral rates. Conclusion: ICU treatment for end-stage COPD and lung cancer is associated with very limited survival. Effective palliative care integration and structured end-of-life decision-making are urgently needed to optimize ICU use.

15 August 2024 in Journal of Pulmonology and Intensive Care
Verified
Journal Article
Open access
PDF file
NBNazan Beyhan
Nazan Beyhan
ZKZehra Dilek Kanmaz
Zehra Dilek Kanmaz
GAGülfidan Aras
Gülfidan Aras
SASedat Altın
Sedat Altın
ETEsin Tuncay
Esin Tuncay
Aims: Hemoptysis can indicate serious, potentially life-threatening conditions. The etiology varies by region and can include tuberculosis (TB) in developing countries and malignancies in developed regions. Methods: This retrospective cohort study reviewed medical records of 400 hospitalized hemoptysis patients between June 2012 and March 2016. Data collected included patient demographics, comorbidities, hemoptysis volume, diagnostic tests, treatments, and outcomes. Survival rates and readmissions were tracked for 2-6 years post-discharge. Results: Of the 400 patients, 88 (22%) were female and 312 (78%) were male. The leading causes of hemoptysis were bronchiectasis (14%), sequela of tuberculosis (TB sequelae; 19%), and malignancy (22.8%). The most common causes in male patients were lung cancer (27.2%) and TB sequelae (21.8%). Bronchiectasis accounted for 28.4% of cases in female patients, followed by drug-induced hemoptysis at 14.8%. The in-hospital mortality rate was 1% (n = 4), with severe hemoptysis present in all four patients who died during admission for hemoptysis. The 2–6-year survival rate was 70.8% for women and 56.1% for men (p = 0.005). The factors found to significantly worsen mortality risk were lung malignancy, age >65, diabetes, and chronic obstructive pulmonary disease (COPD). Conclusion: Overall, lung cancer was found to be the leading cause of hemoptysis, with bronchiectasis being the leading cause in female patients and malignancy in male patients. Close monitoring of male patients is crucial due to higher mortality risk. Careful assessment of patients with hemoptysis having comorbidities such as diabetes and COPD is required due to the reduced survival rates associated with these conditions. Early detection and intervention for lung cancer is essential to optimize the prognosis of affected individuals.